Board of Directors
With an educational background in Pharmacy Bob Kool started his career as pharmacy practitioner in his own pharmacy in Roermond. During this period he was active in the board of the Dutch pharmacist branch organisation (KNMP), section Limburg.
Our Vision is to be the global leaders in delivering medicines that salvage patients suffering from life-threatening inflammation.
Kool was also member of the board of Regifarm, a pharmaceutical wholesale cooperation in Rotterdam, where he was involved in the establishment of a generics division. Together with Jacques Havermans he founded a generics company for the Regifarm Group. Kool worked as a consultant for Arcadis BMB SENTER projects as a pharmaceutical expert in designing and building a factory for the production of generics in Russia and Bulgaria. In 2003, Kool started Basic Pharma together with Jacques Havermans and implemented the business concept of combining pharmaceutical licensing, manufacturing, supply and services under one roof. Kool's main responsibilities are Process & Product development, Business Development and Corporate Strategy.
Harry Relouw is responsible for general and financial management of Matisse. Relouw fills a similar position within Basic Pharma since early 2012 where he safeguards the alignment and execution of Basic Pharma's overall strategy.
He has more than twenty years of international experience in finance and operations, mainly in pharma and biotech. Before joining Matisse in 2014, , Relouw was Director Finance & Control at Prosensa Therapeutics, a Leiden based bio-pharmaceutical company till 2012. At Prosensa Therapeuticshe built the finance organisation of this fast growing company. Relouw was involved in private financing rounds, business planning and implementation of a collaboration agreement with GSK. Prior to Prosensa, Relouw worked in Senior Finance positions at Akzo Nobel, Ericsson, DSM, Rhein Biotech and the Korean based vaccine manufacturer GreenCross Vaccines, a company he helped to integrate in the Rhein Biotech Group. Relouw has a bachelor's degree in Finance & Control.